No consensus is yet available on the function of OPG, but all these studies have concluded that OPG is a promising biomarker for CAD, regardless of whether it plays a protective role against atherosclerosis or causes atherosclerosis with its proatherogenic features. The gene discussed is TNFRSF11B; the disease is atherosclerosis.